1 / 13

Injection Practices in Mongolia

Injection Practices in Mongolia. Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Ministry of Health of Mongolia Phnom Penh, October 2002. Rationale for an Assessment of Injection Practices in Mongolia. High prevalence of infection with HBV and HCV

chaka
Download Presentation

Injection Practices in Mongolia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Ministry of Health of Mongolia Phnom Penh, October 2002

  2. Rationale for an Assessment of Injection Practices in Mongolia • High prevalence of infection with HBV and HCV • 6.4% of children 0-15 years of age HBsAg positive * • 10.7% of children 0-15 years of age anti-HCV positive * • Anecdotal reports of poor injection practices • Injection overuse • Unsafe practices • Political will to engage in a safe and appropriate use of injections policy * 1998-1999 (Davaasuren at al. National Medical University)

  3. “Aimags” Selected Tov Darhan UB Ovorkhangai Dornogobi N Urban (33%), semi-urban (26%) and rural (41%)

  4. Who Gives Injections in Mongolia in 2001? 100% GPs 80% Others Feldshers 60% 40% 20% 0% Nurses Nurses GPs Family Feldshers member Injection providers identified by prescribers (n=21) Population reports regarding 62 last injections

  5. Reported Setting for 62 Last Injections Remembered by the Population, Mongolia 2001 Clinic Home Hospital

  6. Reported Patients’ Preference for Injections, Mongolia 2001 80% 70% 60% 50% Proportion (%) 40% 30% 20% 10% 0% According to According to the population, in the case of fever(n=65) prescribers (n=21)

  7. Awareness Regarding Pathogens Transmitted through Unsafe InjectionsMongolia, 2001 HIV HBV Prescribers Inj. Providers Population HCV Jaundice 0% 20% 40% 60% 80% 100% Proportion (%)

  8. Injection Practices in Mongolia: Strengths • Dramatic improvement of injection practices in Mongolia over the last 10 years • Large use of locally produced new, disposable injection equipment • Good awareness of the risks associated with injections among health-care workers • Efficient health-care waste management despite a lack of sophisticated waste treatment options

  9. Injection Practices in Mongolia: Weaknesses • The ratio of injection per capita in Mongolia is the highest ever reported (13 injections / person-year) • Most injections are given in high-risk settings • Hospitals (nosocomial infections) • Houses (family providers) • Numerous breaks in infection control practices occur, including possible re-use of disposable injection equipment in the absence of sterilization and use of multi-dose vials • Health-care workers are exposed to a high risk of needlestick injuries (2.6 needlesticks / year) • Dangerous practices observed : policy requesting to count used syringes before disposal

  10. Outcomes of the Rapid Assessment • Behaviour change: Development of communication tools • Injection safety policy: Organization of a national workshop on injection safety in Mongolia

  11. Behaviour changes • Development of IEC materials (October 2001) • Promote health-care worker protection • Promote oral drugs in the general population • Engage patients in a consumer demand for safety • Printing of posters, leaflets, brochures ( August 2002)

  12. Injection safety policy in Mongolia • Organisation of a national workshop to institutionalise safe and appropriate use of injections (May 2002) • draft a national injection safety policy • nominate a national injection safety committee • Initial cost collection for costing a plan of action (May 2002)

  13. Perspectives • Develop an injection safety plan of action • Organize group discussion for prescribers and consumers on rational use of injection • Explore options for technology transfer for AD syringes production in Mongolia • Organize universal access to safety boxes (Consider national production) • Assess options for sharps waste management

More Related